SynBiotic SE
FSX:SBX.DE
5.84 (EUR) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | SynBiotic SE |
Symbool | SBX.DE |
Munteenheid | EUR |
Prijs | 5.84 |
Beurswaarde | 31,361,991 |
Dividendpercentage | 0% |
52-weken bereik | 2.86 - 19.5 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Lars Muller |
Website | https://www.synbiotic.com |
An error occurred while fetching data.
Over SynBiotic SE
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)